Literature DB >> 1548760

Differentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cells.

S L Zeichner1, G Hirka, P W Andrews, J C Alwine.   

Abstract

We have examined the transcriptional utilization of the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) under differentiating conditions by using the embryonal carcinoma cell line NTERA-2. NTERA-2 cells undergo two distinct pathways of terminal differentiation, to a neuronal phenotype in response to retinoic acid and to a nonneuronal phenotype in response to hexamethylene bisacetamide. To identify LTR regulatory elements active in each cell type we used a set of HIV LTR linker substitution mutants, which contain mutations that progressively replace adjacent 18-bp segments across the U3 region and into the R region (between nucleotides -453 and +15 relative to the transcription start site). Although each differentiating cell type showed utilization of expected key elements (e.g., NF-kappa B, SP1, TATA) in the 3' portion of the LTR (+1 to -112), the data indicated differentiation-dependent differences in the utilization of these elements. In addition, regions showing dramatic differentiation-dependent effects were detected in the 5' portion of the LTR (-112 to -453), in positions where transcription control elements have not been described previously. The marked differences in the sets of LTR regulatory elements required by each cell type indicate that the LTR can function under a variety of differentiation conditions. Together with previous findings, the data suggest that the complexity of the HIV LTR for transcriptional control is much greater than was previously thought and that the LTR maintains elements which facilitate transcription in many cell types.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548760      PMCID: PMC289020     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes.

Authors:  L M Staudt; H Singh; R Sen; T Wirth; P A Sharp; D Baltimore
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

2.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites.

Authors:  B R Franza; F J Rauscher; S F Josephs; T Curran
Journal:  Science       Date:  1988-03-04       Impact factor: 47.728

4.  An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter.

Authors:  R W Carthew; L A Chodosh; P A Sharp
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

5.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

7.  Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells.

Authors:  B A Fenderson; P W Andrews; E Nudelman; H Clausen; S Hakomori
Journal:  Dev Biol       Date:  1987-07       Impact factor: 3.582

8.  Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element.

Authors:  J D Kaufman; G Valandra; G Roderiquez; G Bushar; C Giri; M A Norcross
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

9.  Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Authors:  J A Garcia; F K Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.

Authors:  F K Wu; J A Garcia; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  13 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 2.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

3.  In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice.

Authors:  J Kurth; J M Buzy; L Lindstrom; J E Clements
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Human brain derived cell culture models of HIV-1 infection.

Authors:  P Seth; E O Major
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.

Authors:  F Canonne-Hergaux; D Aunis; E Schaeffer
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter.

Authors:  M O Lee; P D Hobbs; X K Zhang; M I Dawson; M Pfahl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat.

Authors:  J Y Kim; F Gonzalez-Scarano; S L Zeichner; J C Alwine
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Characterization of nuclear proteins that bind to the regulatory TGATTGGC motif in the human immunodeficiency virus type 1 long terminal repeat.

Authors:  C Schwartz; F Canonne-Hergaux; D Aunis; E Schaeffer
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

9.  Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins.

Authors:  Guerau Fernandez; Thomas D Zaikos; Sohrab Z Khan; Ashley M Jacobi; Mark A Behlke; Steven L Zeichner
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

Review 10.  Confronting proviral HIV infection.

Authors:  David M Margolis
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.